RE:RE:ONCY pelareorep + CAR-T therapy as explained by Mayo ClinicThanks to Noteable, as always.
Science Translational Medicine is perhaps the world's premier journal in its specific domain.
The total market for CAR-T therapy:
The market is expected to grow from $1,037.0 million in 2020 to $3,150.0 million in 2025 at a rate of 24.9%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize $ 6,100 million in 2030.
What the article in Science implies is that pela makes CAR-T work a lot better.
If the whole world of big pharma agrees with these findings, our potential market for pela must be expanding by the month. Again, I ask myself: why have we not been bought out yet? My best answer: we are waiting for panc results.